Autologous peripheral blood stem cell transplantation in malignancies involving bone marrow

Haematologica. 1991 Mar:76 Suppl 1:60-2.

Abstract

Six patients suffering from refractory malignancies (3 NHL, 1 MM, 1 AML, 1 neuroblastoma) received high dose of chemotherapy and autologous peripheral blood stem cell transplantation (APBSCT). The recruitment of PBSC was performed using conventional salvatage schedules of therapy. The patients received a median of 8.69 MNC/kg bw and 20.87 CFU-GM x 10(4)/kg bw. Prompt engraftment occurred in all patients and the median number of days to achieve WBC greater than 1 x 10(9)/l was 16.5 (range 7-26), PMN greater than 0.5 x 10(9)/l was 21.5 (range 6-37) and PLTs greater than 50 x 10(9)/l was 17.5 (range 4-31). Four patients achieved a complete remission. One patient (neuroblastoma) died of progressive disease after a partial response. One patient died in relapse because of drug related toxicity.

MeSH terms

  • Adolescent
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bone Marrow / pathology
  • Combined Modality Therapy
  • Evaluation Studies as Topic
  • Female
  • Hematopoiesis
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Hyperbilirubinemia / chemically induced
  • Hyperbilirubinemia / mortality
  • Italy / epidemiology
  • Middle Aged
  • Neoplasm Recurrence, Local / mortality
  • Neoplasms / blood
  • Neoplasms / drug therapy
  • Neoplasms / therapy*
  • Pancytopenia / chemically induced
  • Remission Induction
  • Transplantation, Autologous